Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Immatics stock

Learn how to easily invest in Immatics stock.

Immatics is a biotechnology business based in the US. Immatics shares (IMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Immatics employs 382 staff and has a trailing 12-month revenue of around $150.9 million.

How to buy Immatics stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – IMTX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Immatics stock price (NASDAQ: IMTX)

Use our graph to track the performance of IMTX stocks over time.

Immatics shares at a glance

Information last updated 2023-02-02.
Latest market close$8.34
52-week range$5.75 - $13.60
50-day moving average $9.25
200-day moving average $9.60
Wall St. target price$19.57
PE ratio 14.5789
Dividend yield $0 (0%)
Earnings per share (TTM) $0.57

Buy Immatics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Immatics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Immatics price performance over time

Historical closes compared with the close of $8.34 from 2023-02-03

1 week (2023-01-31) 2.84%
1 month (2023-01-06) -11.65%
3 months (2022-11-07) -20.11%
6 months (2022-08-05) -33.01%
1 year (2022-02-07) -12.85%
2 years (2021-02-05) -24.52%
3 years (2020-02-03) N/A
5 years (2018-02-03) N/A

Is Immatics stock undervalued or overvalued?

Valuing Immatics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Immatics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Immatics's P/E ratio

Immatics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Immatics shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Immatics's EBITDA

Immatics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $17.7 million.

The EBITDA is a measure of a Immatics's overall financial performance and is widely used to measure a its profitability.

Immatics financials

Revenue TTM $150.9 million
Operating margin TTM 9.18%
Gross profit TTM $-52,811,000
Return on assets TTM 3.13%
Return on equity TTM 45.83%
Profit margin 22.5%
Book value $1.72
Market capitalisation $633.4 million

TTM: trailing 12 months

Immatics share dividends

We're not expecting Immatics to pay a dividend over the next 12 months.

Immatics share price volatility

Over the last 12 months, Immatics's shares have ranged in value from as little as $5.75 up to $13.6. A popular way to gauge a stock's volatility is its "beta".

IMTX.US volatility(beta: 0.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immatics's is 0.5555. This would suggest that Immatics's shares are less volatile than average (for this exchange).

Immatics overview

Immatics N. V. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I clinical trials, which include IMA201 that targets melanoma-associated antigen 4 or 8 in patients with solid tumors; IMA202 that targets melanoma-associated antigen 1 in patients with various solid tumors, including squamous non-small cell lung carcinoma and hepatocellular carcinoma; and IMA203 that targets preferentially expressed antigen in melanoma in adult patients with relapsed and/or refractory solid tumors, as well as IMA204, which is in preclinical studies that targets tumor stroma cell. The company's TCR Bispecifics product candidates, which are in preclinical studies include IMA401, a cancer testis antigen for the treatment of solid tumors; and IMA402 for the treatment of solid tumors. It also develops IMA101 for the treatment of cancer; and IMA301, an allogenic cellular therapy product candidate.

Frequently asked questions

What percentage of Immatics is owned by insiders or institutions?
Currently 29.921% of Immatics shares are held by insiders and 29.319% by institutions.
How many people work for Immatics?
Latest data suggests 382 work at Immatics.
When does the fiscal year end for Immatics?
Immatics's fiscal year ends in December.
Where is Immatics based?
Immatics's address is: Paul-Ehrlich-Strasse 15, Tübingen, Germany, 72076
What is Immatics's ISIN number?
Immatics's international securities identification number is: NL0015285941

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site